Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 3/2018

01-09-2018 | Brief Communication

Frequency of Defective Mismatch Repair System in a Series of Consecutive Cases of Colorectal Cancer in a National Cancer Center

Authors: Patricia E. López-Correa, Leonardo S. Lino-Silva, Armando Gamboa-Domínguez, César Zepeda-Najar, Rosa A. Salcedo-Hernández

Published in: Journal of Gastrointestinal Cancer | Issue 3/2018

Login to get access

Abstract

Background

The frequency of colorectal cancer (CRC) with defective mismatch repair (dMMR) is estimated between 5 and 15%. In our population, the frequency of dMMR is unknown. Our objective was to show the frequency of dMMR.

Methods

Determination of dMMR with immunohistochemistry was performed prospectively for 202 patients who presented consecutively with CRC for the first time at our institution.

Results

The median age was 59 years (IQR 47 to 68), 119 (58.9%) were women, and 43 (21.3%) cases showed dMMR. The only clinicopathological characteristics associated with dMMR were the location in the right colon and the presence of a family history of cancer. In the multivariate analysis, only the presence of the tumor in the right colon was associated with dMMR (OR = 5.823, 95%-C.I. = 2.653–12.784, p < .001).

Conclusion

The 21.3% of the cases demonstrated a dMMR and the only clinical-pathological characteristic associated with dMMR was location in the right colon.
Literature
1.
go back to reference Stewart B, Wild CP. World Cancer Report 2014. Lyon: International Agency for Research on Cancer (IARC); 2014. Stewart B, Wild CP. World Cancer Report 2014. Lyon: International Agency for Research on Cancer (IARC); 2014.
2.
3.
go back to reference Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal Cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10(4):293–300.CrossRefPubMedPubMedCentral Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal Cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: part I. The utility of immunohistochemistry. J Mol Diagn. 2008;10(4):293–300.CrossRefPubMedPubMedCentral
4.
go back to reference Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247–57.CrossRefPubMedPubMedCentral Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349(3):247–57.CrossRefPubMedPubMedCentral
5.
go back to reference Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418(6901):93.CrossRef Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE. Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002;418(6901):93.CrossRef
6.
go back to reference Nowak JA, Hornick JL. Molecular evaluation of colorectal adenocarcinoma: current practice and emerging concepts. Surg Pathol Clin. 2016;9(3):427–39.CrossRefPubMed Nowak JA, Hornick JL. Molecular evaluation of colorectal adenocarcinoma: current practice and emerging concepts. Surg Pathol Clin. 2016;9(3):427–39.CrossRefPubMed
7.
go back to reference Park JH, Powell AG, Roxburgh CS, Horgan PG, McMillan DC, Edwards J. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment. Br J Cancer. 2016;114(5):562–70.CrossRefPubMedPubMedCentral Park JH, Powell AG, Roxburgh CS, Horgan PG, McMillan DC, Edwards J. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment. Br J Cancer. 2016;114(5):562–70.CrossRefPubMedPubMedCentral
8.
go back to reference Egoavil CM, Montenegro P, Soto JL, Casanova L, Sanchez-Lihon J, Castillejo MI, et al. Clinically important molecular features of Peruvian colorectal tumours: high prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations. Pathology. 2011;43(3):228–33.CrossRefPubMed Egoavil CM, Montenegro P, Soto JL, Casanova L, Sanchez-Lihon J, Castillejo MI, et al. Clinically important molecular features of Peruvian colorectal tumours: high prevalence of DNA mismatch repair deficiency and low incidence of KRAS mutations. Pathology. 2011;43(3):228–33.CrossRefPubMed
9.
go back to reference Ortiz C, Dongo-Pflucker K, Martín-Cruz L, Barletta-Carrillo C, Mora-Alferez P, Arias A. Microsatellite instability in patients with diagnostic of colorectal cancer. Rev Gastroenterol Peru. 2016;36(1):15–22.PubMed Ortiz C, Dongo-Pflucker K, Martín-Cruz L, Barletta-Carrillo C, Mora-Alferez P, Arias A. Microsatellite instability in patients with diagnostic of colorectal cancer. Rev Gastroenterol Peru. 2016;36(1):15–22.PubMed
10.
go back to reference Leite SM, Gomes KB, Pardini VC, et al. Assessment of microsatellite instability in colorectal cancer patients from Brazil. Mol Biol Rep. 2010;37:375–80.CrossRefPubMed Leite SM, Gomes KB, Pardini VC, et al. Assessment of microsatellite instability in colorectal cancer patients from Brazil. Mol Biol Rep. 2010;37:375–80.CrossRefPubMed
11.
go back to reference Vaccaro CA, Carrozzo JE, Mocetti E, Berho M, Valdemoros P, Mullen E, et al. Expresion inmunohistoquimica e inestabilidad microsatelital en el sindrome de lynch. Medicina (buenos aires). 2007;67:274–8. Vaccaro CA, Carrozzo JE, Mocetti E, Berho M, Valdemoros P, Mullen E, et al. Expresion inmunohistoquimica e inestabilidad microsatelital en el sindrome de lynch. Medicina (buenos aires). 2007;67:274–8.
12.
go back to reference Montenegro Y, Ramírez-Castro JL, Isaza LF, Bedoya G, Muñetón-Peña CM. Microsatellite instability among patients with colorectal cancer. Rev Med Chil. 2006;134:1221–9.CrossRefPubMed Montenegro Y, Ramírez-Castro JL, Isaza LF, Bedoya G, Muñetón-Peña CM. Microsatellite instability among patients with colorectal cancer. Rev Med Chil. 2006;134:1221–9.CrossRefPubMed
13.
go back to reference Gupta S, Ashfaq R, Kapur P, Afonso BB, Nguyen TPT, Ansari F, et al. Microsatellite instability among individuals of hispanic origin with colorectal cancer. Cancer. 2010;116:4965–72.CrossRefPubMedPubMedCentral Gupta S, Ashfaq R, Kapur P, Afonso BB, Nguyen TPT, Ansari F, et al. Microsatellite instability among individuals of hispanic origin with colorectal cancer. Cancer. 2010;116:4965–72.CrossRefPubMedPubMedCentral
14.
go back to reference Gelsomino F, Barbolini M, Spallanzani A, Pugliese G, Cascinu S. The evolving role of microsatellite instability in colorectal cancer: a review. Cancer Treat Rev. 2016;51:19–26.CrossRefPubMed Gelsomino F, Barbolini M, Spallanzani A, Pugliese G, Cascinu S. The evolving role of microsatellite instability in colorectal cancer: a review. Cancer Treat Rev. 2016;51:19–26.CrossRefPubMed
15.
go back to reference Oh BY, Huh JW, Park YA, Cho YB, Yun SH, Kim HC, et al. Prognostic factors in sporadic colon cancer with high-level microsatellite instability. Surgery. 2016;159(5):1372–81.CrossRefPubMed Oh BY, Huh JW, Park YA, Cho YB, Yun SH, Kim HC, et al. Prognostic factors in sporadic colon cancer with high-level microsatellite instability. Surgery. 2016;159(5):1372–81.CrossRefPubMed
Metadata
Title
Frequency of Defective Mismatch Repair System in a Series of Consecutive Cases of Colorectal Cancer in a National Cancer Center
Authors
Patricia E. López-Correa
Leonardo S. Lino-Silva
Armando Gamboa-Domínguez
César Zepeda-Najar
Rosa A. Salcedo-Hernández
Publication date
01-09-2018
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 3/2018
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-018-0132-1

Other articles of this Issue 3/2018

Journal of Gastrointestinal Cancer 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.